Emergent's bad year continues with House oversight committee demanding documents tied to vaccine screwup
In the latest segment of the Emergent BioSolutions saga, US Rep. Carolyn Maloney (D-NY) and Rep. James Clyburn (D-SC) have sent letters to executives with AstraZeneca and J&J expanding the investigation into the mishap at the CDMO’s Baltimore plant that resulted in millions of doses of Covid-19 being wasted.
The two are chairs of the House Committee on Oversight and Reform and asked in a press release what went wrong in the plant and what led to the signing of federal contracts that were reportedly worth up to $1.5 billion.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.